The in vitro activities of four fluoroquinolone compounds were tested against 92 Escherichia coli strains of ovine and caprine origin under aerobic and anaerobic incubation conditions. The four fluoroquinolones proved to be highly effective against the E. coli isolates tested. When bacteria were cultured anaerobically, at least fourfold increases in the MICs of enoxacin for the strains occurred and no detectable changes in enrofloxacin, sparfioxacin, and ciprofloxacin MICs occurred.
The fluoroquinolone class of compounds includes many extremely potent, broad-spectrum antimicrobial agents with excellent activity against many gram-negative bacteria (16) . This class of antimicrobial agents has shown excellent in vitro activity against Escherichia coli clinical isolates of human origin (6, 15) , including enterotoxigenic E. coli (3, 5, 12) , and many have been used successfully in the prevention and treatment of traveler's diarrhea (4, 9) . In veterinary medicine, fluoroquinolones have been introduced recently and few reports about their in vitro activities against bacterial clinical isolates of animal origin exist (11) . In this report, we describe the results of in vitro activities of four fluoroquinolone compounds (enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin) against E. coli strains isolated from lambs and kids affected by neonatal diarrhea.
We also evaluated the in vitro activities of the four fluoroquinolone compounds against the same E. coli strains grown under anaerobic conditions. Against anaerobic species, activities of fluoroquinolones tend to be lower than against aerobic species (16 Table 1 . The results revealed that the four fluoroquinolones tested have excellent in vitro activities against the E. coli isolates of ovine and caprine origin tested. When bacteria were cultured under aerobic conditions, enoxacin proved to be inhibitory for 90% of the strains at a concentration of 0.125 jig/ml. Enrofloxacin, sparfloxacin, and ciprofloxacin inhibited 90% of the strains at a concentration of '0.062 ,ug/ml. These MICs are considerably lower than MIC breakpoints indicating susceptibility at 1 ,ug/ml for ciprofloxacin and 2 ,ug/ml for enoxacin, enrofloxacin, and sparfloxacin. Thus, all the isolates were highly susceptible to the four quinolone compounds.
The in vitro activities of the fluoroquinolones tested against E. coli strains of ovine and caprine origin are similar to the in vitro activities against isolates of human origin reported previously (3, 15) . However, Pohl et al. (11) have reported that relatively high percentages of E. coli isolates of bovine origin were resistant to enrofloxacin activity in vitro. A high percentage of the isolates investigated by these authors was resistant to nalidixic acid, whereas our isolates were highly susceptible to nalidixic acid. Barry and Fuchs (1) have reported that nalidixic acid-resistant strains of E. coli of human origin required increased concentrations of fluoroquinolones for inhibition.
When bacteria were cultured anaerobically, at least fourfold increases in the MICs of enoxacin for the strains occurred and no detectable changes in enrofloxacin, sparfloxacin, and ciprofloxacin MICs occurred (Table 1) . A lowering in the pH has been reported to increase the MIC of fluoroquinolones (14) . Under 
